Literature DB >> 13065785

Warfarin sodium derivative: (coumadin sodium); an intravenous hypoprothrombinemia-inducing agent.

S SHAPIRO.   

Abstract

Entities:  

Keywords:  COUMARIN/derivatives; PROTHROMBIN TIME/effect of drugs on

Mesh：

Substances：

Year:  1953        PMID： 13065785     DOI： 10.1177/000331975300400410

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  6 in total

1.  STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.

Authors:  R A O'REILLY; P M AGGELER; L S LEONG
Journal:  J Clin Invest       Date:  1963-10       Impact factor: 14.808

2.  Clinical experience with warfarin sodium.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1958-10-11

3.  An evaluation of long-term anticoagulant therapy.

Authors:  M M SUZMAN
Journal:  Postgrad Med J       Date:  1956-04       Impact factor: 2.401

4.  Pharmacokinetic Modeling of Warfarin ІI - Model-based Analysis of Warfarin Metabolites following Warfarin Administered either Alone or Together with Fluconazole or Rifampin.

Authors:  Shen Cheng; Darcy R Flora; Allan E Rettie; Richard C Brundage; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2022-07-07       Impact factor: 3.579

Review 5.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 6.  Factor Xa inhibitors: critical considerations for clinical development and testing.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2021-05-15       Impact factor: 2.300
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.